![Christopher Kevil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Christopher Kevil was the founder of TheraVasc, Inc. which was founded in 2008, where he held the title of Chief Scientific Officer from 2008 to 2016.
He also worked as Director-Vascular Biology & Angiogenesis at LSU Health System Health Care Services Division.
Dr. Kevil holds a doctorate degree from Louisiana State University and an undergraduate degree from Northwestern State University.
Antiguos cargos conocidos de Christopher Kevil.
Empresas | Cargo | Fin |
---|---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Fundador | 01/01/2016 |
LSU Health System Health Care Services Division | Corporate Officer/Principal | - |
Formación de Christopher Kevil.
Louisiana State University | Doctorate Degree |
Northwestern State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
LSU Health System Health Care Services Division |
- Bolsa de valores
- Insiders
- Christopher Kevil